Pembrolizumab plus lenvatinib as first-line treatment for advanced non-clear cell kidney cancer
Immunotherapy combinations are becoming the standard treatment after surgery for [...]
Immunotherapy combinations are becoming the standard treatment after surgery for [...]
TIVO-3 was a phase 3 clinical trial that compared tivozanib, [...]
Adjuvant therapy aims to reduce the risk of the cancer [...]
Stereotactic ablative radiotherapy (SABR) for treating the primary kidney cancer [...]
Patients with advanced cancer want to live a good quality [...]
This study looked at the incidence, diagnosis and treatment of [...]
The standard treatment for small renal masses is to remove [...]
Further follow-up data from the phase 3 CLEAR study with [...]
Updated results and further follow up from the CaboNivo study [...]
The results of a study with a new anti-cancer medication [...]